XOMA Royalty Corporation - Common Stock — Cash Flow (NASDAQ:XOMA) | MetaTrader

Open full chart Full chart

Financials

Overview Statement Statistics Dividends

Quarterly Annual

Cash from operating activities 10.09 M22.68 M-12.88 M-18.16 M-13.75 M2.87 M 6.79 M Cash from investing activities -209 K-26.5 M-20.22 M-711 K-28.26 M50.89 M 64.13 M Cash from financing activities 19.79 M12.84 M-4.45 M120.59 M-11.13 M-26.46 M -27.21 M Free cash flow 10.09 M22.68 M-28.13 M-18.16 M-13.75 M-17.85 M 6.79 M

News

Goldman Sachs Hits Record High, Leads 15 Newcomers To Best Growth Stock Lists

Oncobiologics, Inc. (OTLK) Reports Q2 Loss, Lags Revenue Estimates

Kyntra Bio (KYNB) Reports Q1 Loss, Tops Revenue Estimates

CG Oncology, Inc. (CGON) Reports Q1 Loss, Tops Revenue Estimates

Entrada Therapeutics, Inc. (TRDA) Reports Q1 Loss, Misses Revenue Estimates

Tarsus Pharmaceuticals, Inc. (TARS) Reports Q1 Loss, Beats Revenue Estimates

XOMA Royalty (XOMA) Moves 10.7% Higher: Will This Strength Last?

Royalty Powerhouse: Ligand And Xoma Unite In $739 Million Deal

Exclusive | Ligand Pharmaceuticals Is Buying Xoma for Nearly $740 Million

Turbine Season for Tech: John Rowland on the Next Era of AI Data Center Investments

XOMA Royalty Corporation (XOMA) Q4 2025 Earnings Call Transcript

XOMA Royalty Jumps After Q4 Double Beat, Signals Pipeline Catalysts Ahead - XOMA Royalty (NASDAQ:XOMA)